Table 2.
Author | Strain | Sex | Age at Intervention | Animals per Group | Study Design | Intervention | Accompanying Conditions | Frequency of Intervention (Occasions) | Comparator | Outcome |
---|---|---|---|---|---|---|---|---|---|---|
Aasland et al. 2010 [22] | C57BL/6JBomTac | M | NR | n = 8 | RCT (crossover) | Saphenous vein Tail vein |
N/A | 4 by both methods at 2 weeks apart | Each other Time series |
Plasma glucose Hemolysis |
Abatan et al. 2008 [9] | ICR | F | NR | n = 8–13 (unclear from methods) | RCT | Saphenous vein Tail tip amputation |
N/A | One-off collection Serial sample at 2–3 day intervals (4) |
Each other Time series |
Plasma corticosterone Behaviours noted during blood collection |
Christensen et al. 2009 [23] | C57BL/6JBom | M | NR | n = 20 | RCT | All sample methods were performed at 21 and 30 °C, i.e., 8 experimental groups Retrobulbar Tail incision Tail tip amputation Tail tip puncture |
N/A | Serial sample at 30 min intervals (4) | Other groups | Blood glucose Haemolysis Clotting |
Durschlag et al. 1996 [24] | ICR | M | 9 weeks | n = 8 | Case report | Tail incision | N/A | Serial sample at 2–3 day intervals (5) | Time series | Histology Plasma corticosterone |
Fernandez et al. 2009 [25] | C57BL/6J | M | 6 weeks | n = 10 | RCT (crossover) | Retrobulbar Facial vein |
Anaesthesia (retrobulbar) | Serial sample at 6–8 week intervals (3) | Each other | Blood glucose Haemolysis |
Forbes et al. 2010 [26] | Balb/c | F | 6–8 weeks | n = 214 | Retrospective case series | Facial vein | Lancet or needle for sampling | Serial sample at 2–7 day intervals (6) | Nil | Mortality |
Francisco et al. 2015 [27] | BALB/c | F | 5 weeks | n = 20 | RCT | Facial vein (lancet or needle) |
Facial vein route with anaesthesia as one group |
One-off collection | Other groups | Adverse events Gross post-mortem site evaluation |
Fried et al. 2015 [28] | C57BL/6N background with a mutation in MDA5 | M/F | 4–6 months | n = 8 | RCT | Retrobulbar | Anaesthesia | One-off collection | Time series at 0, 1, 3, 7 or 14 days after sampling | Clinical scores Histology |
Frolich et al. 2018 [29] | C57BL/6NCrl | F | 12–14 weeks | n = 12 | RCT | Retrobulbar Facial vein |
Anaesthesia (retrobulbar) | One-off collection Serial sample at 1 wk intervals (6) |
Each otherSingle versus serial | Adverse events Mortality Bodyweight Histology Plasma glucose |
Gjendal et al. 2020 [30] | C57BL/6 | F | 10 weeks | n = 30 | RCT | Retrobulbar Facial vein Sublingual |
Anaesthesia (retrobulbar) Facial vein and sublingual anaesthesia groups, in addition to conscious sampling |
Serial sample at days 8, 9, and 10 (short protocol) and days 8, 15, and 22 (long protocol) | Eachother Single versus serial |
Nest build score Faecal corticosteroid metabolites Bodyweight Haemolysis Clotting Gross post-mortem site evaluation |
Harikrishnan et al. 2018 [12] | C57BL/6NTac | M/F | 6 weeks | n = 12 | RCT | Retrobulbar Sublingual Facial vein Tail incision |
Anaesthesia (retrobulbar) | Serial sample at 24 h interval (2) | Other groups, plus isoflurane control, and behavioural test control (naïve animals) | Nest build score Elevated plus maze Open field test Faecal corticosteroid metabolites |
Heimann et al. 2009 [4] | Crl: CD-1 [CR] | M/F | 11 weeks | n = 30 | RCT | Sublingual Retrobulbar |
Anaesthesia | One-off collection | Each other | Histology |
Heimann et al. 2010 [1] | CD1 | F | 14 weeks | n = 18 | RCT | Sublingual Facial vein |
Anaesthesia (for sublingual and one facial vein group) | One-off collection | Other groups, time series at 3 h, two or five days after sampling | Bodyweight Food intake Histology Blood glucose |
Kim et al. 2018 [10] | CD-1 C57BL/6 |
M | NR | n = 4–6 | RCT | Retrobulbar Tail tip amputation |
Anaesthesia (retrobulbar) Restrain/unrestrained |
One-off collection Serial sample tail tip groups at 30 min intervals (5) |
Other groupsTime series | Plasma corticosterone |
Madetoja et al. 2009 [31] | Hsdwin:NMRI | F | 9 weeks | n = 10 | RCT | Saphenous vein Facial vein Tail vein |
Tail warming heat lamp | One-off collection | Other groups, and control with no blood samples | Plasma corticosterone Plasma ACTH |
Moore et al. 2017 [32] | C57BL/6J | M | 10–12 weeks | n = 8–12 | RCT | Facial vein Tail tip amputation Tail incision |
N/A | One-off collection | Other groups, and sham submandibular and tail tip amputation (just restraint) | Blood glucose Audible vocalisations Post-procedural epochs of inactivity Grooming behaviour Nest build score Elevated plus maze Open field test Histology |
Regan et al. 2016 [33] | CD1 | F | 12–13 weeks | n = 15 | RCT | Retrobulbar Facial vein Submental |
Anaesthesia (retrobulbar) | Serial sample at 2 week intervals (3) | Other groups | Adverse events Bodyweight Extraneous blood loss Gross post-mortem site evaluation Haemolysis Clotting |
Rogers et al. 1999 [34] | Study 1 (single sample) C57BL/6 | F | 10–12 weeks | n = 72 | RCT (crossover) | Retrobulbar | Thermostatic warming chamber | One-off collection (each method) | Each other | Plasma glucose |
Study 2 (repeated sample) C57BL/6 | F | 10–12 weeks | n = 48 | Tail incision | Serial sample at 1 week interval (2) | Plasma insulin | ||||
Sadler et al. 2013 [7] |
Study 1 (single sample) BALB/CAnNCrl Study 2 (repeated sample) BALB/CAnNCrl |
M M |
7–8 weeks 3–4 weeks |
n = 5 n = 4/5 |
RCT | Tail incision Tail vein Tail incision |
Thermostatic warming chamber Tail dipped hot water |
One-off collection Serial sample at 24 h intervals (3) |
Other groups Time series |
Plasma corticosterone |
Shirasaki et al. 2012 [35] | ICR C57BL/6N |
M | 6 weeks | n = 10 (unclear from methods) | RCT | Jugular Tail incision |
N/A | One-off collection Serial sample at 24 h intervals (5) |
Each other Time series |
Plasma CRP Plasma corticosterone Plasma haemoglobin Hematocrit Plasma thrombin–antithrombin complexes |
Sorenson et al. 2019 [36] | C57BL/6NTac | F | 8 weeks | n = 36 | RCT | Retrobulbar Saphenous Sublingual Facial vein Tail incision Tail tip amputation |
Anaesthesia (retrobulbar) | One-off collection | Each other, plus isoflurane control and naïve animals (no bleeding) Time series at nine timepoints: 6 or 10 h or 1, 2, 4, 6, 8, 10, or 12 days after sampling |
Bodyweight Stomach contents Plasma corticosterone Inflammatory gene expression at sample site Plasma inflammatory markers (haptoglobin and IL1ß) Histology |
Tabata et al. 1998 [37] |
Study 1 (single sample) B6C3Fl/ICR Study 2 (repeated sample) B6C3Fl |
M/F M/F |
8 weeks 9 weeks |
n = 12 n = 20 |
RCT | Tail tip amputation | Tube restraint or anaesthetized with ether or pentobarbital § | One-off collection Serial sample at varied intervals for 24 h (8) |
Other groups Time series |
Plasma glucose |
Teilmann et al. 2014a [2] | BomTac:NMRI | M | 6–8 weeks | n = 8–18 | RCT | Facial vein Tail vein |
N/A | Two day and two night samples within 24 h (4) | Other groups, plus controls (no blood sample and naïve animals as behavioural control) | Bodyweight Plasma corticosterone Faecal corticosteroid metabolites Triple test (elevated plus maze, open field test, light–dark box) |
Teilmann et al. 2014 [38] | C57BL/6J | M | 5 months | n = 8–12 | RCT | Retrobulbar Facial vein |
N/A | One-off collection | Other group, plus control (no blood sample) | Bodyweight Plasma corticosterone Histology |
Tsai et al. 2015 [8] | BALB/cO1aHsd | F | 8 weeks | n = 12 | RCT | Jugular Retrobulbar (with and without anaesthesia) Saphenous Facial vein Tail vein |
Anaesthesia (retrobulbar group and jugular) | One-off collection | Other groups | In-cage activity Plasma corticosterone Open field test Histology |
Tuli et al. 1995 [11] |
Study 1 (acute stress) BALB/c/Ola Study 2 (tail bleeding recovery) BALB/c/Ola |
M M |
5–6 months 5–6 months |
n = 5 n = 5 |
RCT | Tail tip amputation | Tail dipped hot water | One-off collection each route Serial humane killing at day 2, 4 and 8 after blood sample |
Other groups and control with no tail amputation | Plasma corticosterone Adrenal weight Spleen weight |
Voigt et al. 2013 [13] | C57BL/6CrlN | F | 4–6 months | n = 36 (16 contributed to final results due to technical failure) | RCT (crossover) | Blood-sucking bug Retrobulbar Tail incision |
Anaesthesia (retrobulbar) | One-off collection each route (note crossover design) | Other groups | Faecal corticosteroid metabolites |
NR—not reported. §—The aim of this section of the study was to investigate common scenarios, such as anaesthesia, which elevated blood glucose in laboratory mice, rather than investigate the blood sampling technique per se. The reviewers still considered the study was worthy of inclusion since it could provide data on the topic but have only extracted data relevant to the review question. Note: Restraint not included as an accompanying condition unless effects of this specifically investigated as part of study design, since this would be needed for all sample routes.